The Influenza Centre"> New Publications | news

New Publications

New Publications in 2014 (Updated 21.08.2014)
1.
Marti GP, Mohn KG, Cox RJ, Brokstad KA.
The influence of tonsillectomy on total serum antibody levels.
Scand J Immunol. 2014 Jul 16. doi: 10.1111/sji.12213. [Epub ahead of print]

2.
Pedersen GK, Sjursen H, Nøstbakken JK, Jul-Larsen A, Hoschler K, Cox RJ.
Matrix MTM adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4+ T cell responses in man.
Hum Vaccin Immunother. 2014 Jun 23;10(8). [Epub ahead of print]

3.
Pedersen GK, Höschler K, Oie Solbak SM, Bredholt G, Pathirana RD, Afsar A, Breakwell L, Nøstbakken JK, Raae AJ, Brokstad KA, Sjursen H, Zambon M, Cox RJ.
Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.
Vaccine. 2014 Jul 31;32(35):4550-7. doi: 10.1016/j.vaccine.2014.06.009. Epub 2014 Jun 18.

4.
Krammer F, Jul-Larsen A, Margine I, Hirsh A, Sjursen H, Zambon M, Cox RJ.
An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans.
Clin Vaccine Immunol. 2014 Aug;21(8):1153-63. doi: 10.1128/CVI.00272-14. Epub 2014 Jun 18.

5.
Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Báez C, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Iglesias AL, Hoger PH, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Knight M, Kudo K, Kusznierz G, Kuzman I, Kwan AM, Amine IL, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Mayo-Montero E, McGeer A, Memish Z, Metan G, Mickiene A, Mikić D, Mohn KG, Moradi A, Nymadawa P, Oliva ME, Ozkan M, Parekh D, Paul M, Polack FP, Rath BA, Rodríguez AH, Sarrouf EB, Seale AC, Sertogullarindan B, Siqueira MM, Skręt-Magierło J, Stephan F, Talarek E, Tang JW, To KK, Torres A, Törün SH, Tran D, Uyeki TM, Van Zwol A, Vaudry W, Vidmar T, Yokota RT, Zarogoulidis P; PRIDE Consortium Investigators, Nguyen-Van-Tam JS.
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Lancet Respir Med. 2014 May;2(5):395-404. doi: 10.1016/S2213-2600(14)70041-4. Epub 2014 Mar 19.

6.
Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, García-Sastre A, Palese P.
Divergent H7 immunogens offer protection from H7N9 virus challenge.
J Virol. 2014 Apr;88(8):3976-85. doi: 10.1128/JVI.03095-13. Epub 2014 Jan 22.

7.
Olberg HK, Cox RJ, Nostbakken JK, Aarseth JH, Vedeler CA, Myhr KM.
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Mult Scler. 2014 Jan 16;20(8):1074-1080. [Epub ahead of print]

8.
Krammer F, Cox RJ.
The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines.
Expert Rev Vaccines. 2013 Dec;12(12):1369-72. doi: 10.1586/14760584.2013.850036. Epub 2013 Oct 25. No abstract available.

9.
Mann AJ, Noulin N, Catchpole A, Stittelaar KJ, de Waal L, Veldhuis Kroeze EJ, Hinchcliffe M, Smith A, Montomoli E, Piccirella S, Osterhaus AD, Knight A, Oxford JS, Lapini G, Cox R, Lambkin-Williams R.
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.
PLoS One. 2014 May 21;9(5):e93761. doi: 10.1371/journal.pone.0093761. eCollection 2014.

10.
Nachbagauer R, Wohlbold TJ, Hirsh A, Hai R, Sjursen H, Palese P, Cox RJ, Krammer F.
Induction of broadly-reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans.
Journal of Virology 2014 in press.

11.
Skrede S, Steinsland H, Sommerfelt H, Aase A, Brandtzaeg P, Langeland N, Cox RJ, Sævik M, Wallevik M, Skutlaberg DH, Tellevik MG, Sack DA, Nataro JP, Guttormsen AB.
Experimental infection of healthy volunteers with enterotoxigenic Escherichia coli wild-type strain TW10598 in a hospital ward.
BMC Infectious Diseases 2014 in press.

12.
Mair-Jenkins J, Saavedra-Campos M, Baillie K, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD; Convalescent Plasma Study Group, Nguyen-Van-Tam JS, Beck CR.
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: a systematic review and exploratory meta-analysis.
J Infect Dis. 2014 Jul 16. pii: jiu396. http://www.ncbi.nlm.nih.gov/pubmed/25030060

13.
Major D, Chichester J, Pathirana R, Guilfoyle K, Guzman C, Yusibov V, Cox RJ.
Intranasal vaccination with a plant-derived H5 vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
Human Vaccines & Immunotherapeutics submitted 2013.